Author: healthadmin
From the majestic canyons of the Grand Canyon to the granite peaks of Yosemite National Park to the ancient trees of Alaska’s Tongass National Forest, President Donald Trump has promised to make America’s federal preserves “beautiful again.” National parks make up part of more than 600 million acres (243 million hectares) of U.S. public lands spanning forests, deserts, waterways, and wildlife refuges. “These lands include some of the most ecologically pristine and biodiverse lands in the country,” said Jenny Roland Shea, director of public lands policy at the Center for American Progress, a Washington-based think tank. But critics say these…
The UK can now officially declare that pharmaceutical exports to the US are duty-free after the UK government signed the landmark US-UK Pharmaceutical Partnership, which was first launched in December. The UK will increase the net price the NHS pays for new treatments by 25% in exchange for a tariff holiday. The deal, which will last for at least three years, will make Britain the first country in the world to impose zero percent tariffs on U.S. pharmaceutical exports, British officials said in a press release Thursday. “The partnership, first announced in December, will protect the UK’s pharmaceutical industry, which…
A medical device company spun out from Northumbria University has reached a key milestone. Receives CE Mark for an exhaled breath sampling platform that has been demonstrated in peer-reviewed studies to reliably collect saliva-free exhaled breath condensate (EBC) from deep within the lungs, making it the first technology of its kind to achieve this distinction. PulmoBioMed Ltd has been awarded the CE mark for its PBM-Hale™ platform, a non-invasive breath sampling device developed based on research carried out at Northumbria University in Newcastle. The CE-marked and US FDA-registered device is now available for deployment in clinical and research settings in…
Corti, a maker of AI-based models for healthcare, has released a new agent model for medical coding that outperforms many Big Tech models. Symphony for Medicalcoding outperforms OpenAI, Anthropic, Amazon, Oracle, and Google benchmarks by more than 25% on clinical accuracy benchmarks. The product, available via API, is built on Corti’s flagship model Symphony, which is already used by 200 teams in the US today. The company works with EHR vendors, virtual care platforms, practice management systems, and life sciences organizations around the world. Medical coding is extremely complex. The U.S. coding system, ICD-10, has approximately 70,000 diagnosis codes. Automated…
The National Comprehensive Cancer Network® (NCCN®), a coalition of leading cancer centers, announces the 2026 winners of the annual NCCN Foundation® Young Investigator Awards. This award provides early career researchers with funding to advance research on important issues in oncology. Award recipients were selected by the NCCN Oncology Research Program (ORP), which provides oversight and guidance throughout the two-year program. “NCCN is committed to providing the most effective treatment for patients with cancer,” said Dr. Crystal S. Denlinger, CEO of NCCN. “NCCN’s junior investigators will continue to serve in leadership roles within the agency and nationally. This year’s honorees have…
Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Institute (OSUCCC – James) are advancing the understanding of a promising blood test that could personalize treatment and monitoring for patients with human papillomavirus (HPV)-related throat cancer. This study JAMA Otorhinolaryngology – Head and Neck Surgeryinvestigates how circulating tumor HPV DNA (ctDNA), a blood-based test, changes before and after surgery. This study investigates how tumor biology and patient factors influence ctDNA levels. This discovery provides important new insights into how this ctDNA test can be used in conjunction with pathology reports…
With the U.S. approval of a second oral GLP-1 drug to treat obesity, analysts are starting to analyze the potential for Eli Lilly’s Foundayo to become a blockbuster hit in 2026, as well as Novo Nordisk’s similarly hot pill Wigovy, which was launched three months ahead of Lilly’s drug in January. Meanwhile, Novo, which appears intent on maintaining its first-mover advantage in the obesity drug space, has launched an aggressive defense, focusing on the company’s claims that the weight loss of oral Wigovy vs. Foundayo is “substantially greater.” With the FDA’s approval of Foundayo (orforglipron) on Wednesday, Lilly announced that…
A critical challenge in global healthcare and biotechnology is the “cold chain,” or the refrigerated storage and transportation networks needed to prevent degradation of protein-based medicines, vaccines, and diagnostic tests. This dependence on constant low temperatures is expensive and energy-intensive, often failing in areas lacking reliable power and leading to high waste rates. Now, a team from Oxford University’s School of Engineering has tested a promising alternative: a simple room-temperature drying technique that traps functional proteins in a stable sugar-based ‘glass’. In a paper published in engineeringResearchers led by Professor Zhanfeng Cui detailed the success of matrix-assisted room temperature (MART)…
Google’s plans to partner with a natural gas power plant that could provide energy to one of its data centers in Texas have been revealed in a new investigation and confirmed by the company. The move is part of an ongoing pivot at the tech giant, which once pledged to become carbon neutral by 2030 and has long been considered a pioneer in clean energy.The gas power plant will be built in Armstrong County, a sparsely populated area of the Texas Panhandle. According to a report by research group Cleanview, the project is being led by Crusoe Energy, which is…
A research team led by Botondo Roska from the Institute of Molecular Ophthalmology Basel (IOB), together with colleagues, has discovered a genetic pathway and a compound that helps protect cone photoreceptors. These cells are damaged in diseases such as age-related macular degeneration, which is a major cause of vision loss. Cone photoreceptors are concentrated in the macula and are essential for reading, recognizing faces, and recognizing colors. When these cells die, central vision is lost, as in many inherited retinal diseases and macular degeneration. Despite decades of scientific effort, no approved treatments can stop this process. This study, led by…